Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 2;6(4):00520-2020.
doi: 10.1183/23120541.00520-2020. eCollection 2020 Oct.

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey

Catharina Belge  1   2 , Rozenn Quarck  1   2 , Laurent Godinas  1 , David Montani  3   4   5 , Pilar Escribano Subias  6 , Jean-Luc Vachiéry  7 , Heba Nashat  8 , Joanna Pepke-Zaba  9 , Marc Humbert  3   4   5 , Marion Delcroix  1
Affiliations

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey

Catharina Belge et al. ERJ Open Res. .

Abstract

This international survey highlights that a limited number of PAH and CTEPH patients suffered from severe #COVID19 infection https://bit.ly/3jGuBQq.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: C. Belge reports personal fees from Actelion/Janssen and MSD/Bayer outside the submitted work. Conflict of interest: R. Quarck has nothing to disclose. Conflict of interest: L. Godinas reports personal fees from Actelion outside the submitted work. Conflict of interest: D. Montani reports grants and personal fees from Actelion and Bayer, personal fees from GSK and Pfizer, grants, personal fees and nonfinancial support from MSD, personal fees from Chiesi and Boerhinger, and nonfinancial support from Acceleron, outside the submitted work. Conflict of interest: P. Escribano Subias reports personal fees and grants from Janssen, and personal fees from MSD, GlaxoSmithKline and Ferrer, outside the submitted work. Conflict of interest: J-L. Vachiery reports grants from Actelion J&J, and other support from Bayer HealthCare, Bial Portela, PhaseBio, Respira Therapeutics and United Therapeutics, outside the submitted work. Conflict of interest: H. Nashat reports grants from Actelion Pharmaceuticals outside the submitted work. Conflict of interest: J. Pepke-Zaba reports grants, personal fees and nonfinancial support from Actelion, grants and personal fees from Merck, and personal fees from Bayer, outside the submitted work. Conflict of interest: M. Humbert reports grants and personal fees from Actelion, and personal fees from GSK, Merck and Acceleron, outside the submitted work. Conflict of interest: M. Delcroix reports grants and other support from Actelion/J&J, and other support from Bayer, MSD, Reata, Bellarophon and Acceleron, outside the submitted work.

Figures

FIGURE 1
FIGURE 1
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients. a) Table showing number of participating centres, reported COVID-19 cases and COVID-19 related mortality per country in 47 centres from 28 countries worldwide. b) Age distribution of patients (n=70).
See this image and copyright information in PMC

References

    1. CDC People at increased risk and other people who need to take extra precautions. www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complication... Date last updated: 11 September 2020. Date last accessed: 25 May 2020.
    1. Padang R, Chandrashekar N, Indrabhinduwat M, et al. . Aetiology and outcomes of severe right ventricular dysfunction. Eur Heart J 2020; 41: 1273–1282. doi:10.1093/eurheartj/ehaa037 - DOI - PubMed
    1. Campo A, Mathai SC, Le PJ, et al. . Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J 2011; 38: 359–367. doi:10.1183/09031936.00148310 - DOI - PubMed
    1. Sztrymf B, Souza R, Bertoletti L, et al. . Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J 2010; 35: 1286–1293. doi:10.1183/09031936.00070209 - DOI - PubMed
    1. Haddad F, Peterson T, Fuh E, et al. . Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail 2011; 4: 692–699. doi:10.1161/CIRCHEARTFAILURE.110.949933 - DOI - PubMed

LinkOut - more resources